{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:48:17Z","timestamp":1789386497803,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1983,1,1]],"date-time":"1983-01-01T00:00:00Z","timestamp":410227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1983,1,1]],"date-time":"1983-01-01T00:00:00Z","timestamp":410227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[1983]]},"DOI":"10.1016\/0306-4530(83)90045-8","type":"journal-article","created":{"date-parts":[[2003,4,25]],"date-time":"2003-04-25T05:45:10Z","timestamp":1051249510000},"page":"95-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Failure of naloxone to reverse apomorphine effects in humans"],"prefix":"10.1016","volume":"8","author":[{"given":"Michael C.","family":"Rowbotham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall S.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reese T.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanny C.","family":"Keil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/0306-4530(83)90045-8_BIB1","series-title":"AMA Drug Evaluations","first-page":"1437","article-title":"General antidotes","author":"American Medical Association","year":"1980"},{"key":"10.1016\/0306-4530(83)90045-8_BIB2","first-page":"460","article-title":"Heterologous radioimmunoassay for plasma human prolactin","volume":"77","author":"Aubert","year":"1974","journal-title":"Acta Endocr."},{"key":"10.1016\/0306-4530(83)90045-8_BIB3","first-page":"363","article-title":"Effects of naloxone upon prolactin and cortisol in normal women","volume":"164","author":"Blankstein","year":"1980"},{"key":"10.1016\/0306-4530(83)90045-8_BIB4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0031-6997(25)07328-4","article-title":"Physiology and pharmacology of vomiting","volume":"5","author":"Borison","year":"1953","journal-title":"Pharmac. Rev."},{"key":"10.1016\/0306-4530(83)90045-8_BIB5","first-page":"123","article-title":"Distribution Free Statistical Tests","author":"Bradley","year":"1968"},{"key":"10.1016\/0306-4530(83)90045-8_BIB6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00735817","article-title":"Therapeutic efficacy of a combination of apomorphine with sulpiride or metaclopramide in Parkinsonism","volume":"47","author":"Corsini","year":"1976","journal-title":"Psychopharmacology"},{"key":"10.1016\/0306-4530(83)90045-8_BIB7","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1212\/WNL.28.11.1805","article-title":"Enkephalins and nigrostriatal function","volume":"28","author":"Diamond","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/0306-4530(83)90045-8_BIB8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1054-3589(08)60482-2","article-title":"Pharmacology and neurochemistry of apomorphine","volume":"15","author":"DiChiara","year":"1978","journal-title":"Adv. Pharmac. Chemother."},{"key":"10.1016\/0306-4530(83)90045-8_BIB9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0014-2999(77)90023-1","article-title":"Behavioral interactions between naloxone and dopamine agonists","volume":"43","author":"Harris","year":"1977","journal-title":"Eur. J. Pharmac."},{"key":"10.1016\/0306-4530(83)90045-8_BIB10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF02584090","article-title":"The addiction research inventory: appendix","volume":"4","author":"Hill","year":"1963","journal-title":"Psychopharmacologia"},{"key":"10.1016\/0306-4530(83)90045-8_BIB11","series-title":"Endorphins in Mental Health Research","first-page":"484","article-title":"Naloxone-induced mood and physiologic changes in normal volunteers","author":"Jones","year":"1979"},{"key":"10.1016\/0306-4530(83)90045-8_BIB12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archpsyc.1980.01780180097012","article-title":"Naloxone-induced behavioral and physiological effects in normal and manic subjects","volume":"37","author":"Judd","year":"1980","journal-title":"Archs. gen. Psychiat."},{"key":"10.1016\/0306-4530(83)90045-8_BIB13","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1172\/JCI107135","article-title":"The ontogenesis of human fetal hormones. 1. Growth hormone and insulin","volume":"51","author":"Kaplan","year":"1972","journal-title":"J. clin. Invest."},{"key":"10.1016\/0306-4530(83)90045-8_BIB14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1210\/endo-100-1-30","article-title":"Reduction in plasma vasopressin levels of dehydrated rats following acute stress","volume":"100","author":"Keil","year":"1977","journal-title":"Endocrinology"},{"key":"10.1016\/0306-4530(83)90045-8_BIB15","series-title":"The Pharmacologic Basis of Therapeutics","first-page":"1602","article-title":"Principles of toxicology","author":"Klaasen","year":"1980"},{"key":"10.1016\/0306-4530(83)90045-8_BIB16","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1210\/jcem-37-5-719","article-title":"Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum","volume":"37","author":"Lal","year":"1973","journal-title":"J. clin. Endocr. Metab."},{"key":"10.1016\/0306-4530(83)90045-8_BIB17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1600-0447.1979.tb06959.x","article-title":"Effect of naloxone or levallorphan on serum prolactin concentrations and apomorphine-induced growth hormone secretion","volume":"59","author":"Lal","year":"1979","journal-title":"Acta psychiat. scand."},{"key":"10.1016\/0306-4530(83)90045-8_BIB18","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0002-9343(77)90545-9","article-title":"Apomorphine-stimulated growth hormone release","volume":"63","author":"LaRossa","year":"1977","journal-title":"Am. J. Med."},{"key":"10.1016\/0306-4530(83)90045-8_BIB19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/jcem-50-3-569","article-title":"Evidence for endogenous opioid control of vasopressin release in man","volume":"50","author":"Lightman","year":"1980","journal-title":"J. clin. Endocr. Metab."},{"key":"10.1016\/0306-4530(83)90045-8_BIB20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0022-510X(79)90069-8","article-title":"Naloxone blockade of apomorphine-induced stereotyped behavior","volume":"43","author":"Margolin","year":"1979","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/0306-4530(83)90045-8_BIB21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0006-8993(79)90142-2","article-title":"Failure of naloxone to influence physiological growth hormone and prolactin secretion","volume":"168","author":"Martin","year":"1979","journal-title":"Brain Res."},{"key":"10.1016\/0306-4530(83)90045-8_BIB22","first-page":"70","article-title":"Ipecae syrup and activated charcoal for treatment of poisoning in children","volume":"21","author":"Medical Letter","year":"1979","journal-title":"Med. Lett. Drugs Ther."},{"key":"10.1016\/0306-4530(83)90045-8_BIB23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/j.1552-4604.1978.tb02427.x","article-title":"An apomorphine-induced vomiting model for antiemetic studies in man","volume":"18","author":"Proctor","year":"1978","journal-title":"J. clin. Pharmac."},{"key":"10.1016\/0306-4530(83)90045-8_BIB24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0361-1124(73)80077-2","article-title":"Apomorphine-naloxone controlled rapid emesis","volume":"2","author":"Rausten","year":"1973","journal-title":"J. Am. Coll. Emerg. Physicians"},{"key":"10.1016\/0306-4530(83)90045-8_BIB25","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/ki.1979.189","article-title":"Influence of the emetic reflex on vasopressin release in man","volume":"16","author":"Rowe","year":"1979","journal-title":"Kidney Int."},{"key":"10.1016\/0306-4530(83)90045-8_BIB26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0361-1124(76)80161-X","article-title":"A clinical comparison of syrup of ipecac and apomorphine use in adults","volume":"5","author":"Schofferman","year":"1976","journal-title":"J. Am. Coll. Emerg. Physicians"},{"key":"10.1016\/0306-4530(83)90045-8_BIB27","first-page":"F321","article-title":"Osmotic and nonosmotic control of vasopressin release","volume":"236","author":"Schrier","year":"1979","journal-title":"Am. J. Physiol."},{"key":"10.1016\/0306-4530(83)90045-8_BIB28","first-page":"261A","article-title":"Effect of naloxone on adrenocorticotropin, growth hormone and prolactin in patients with secretory pituitary tumors","volume":"27","author":"Tolis","year":"1979","journal-title":"Clin. Res."},{"key":"10.1016\/0306-4530(83)90045-8_BIB29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0306-4530(80)90026-8","article-title":"Short-term hormonal effects of naloxone in man","volume":"5","author":"Volavka","year":"1980","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/0306-4530(83)90045-8_BIB30","first-page":"38","article-title":"Biostatistical Analysis","author":"Zar","year":"1974"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0306453083900458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0306453083900458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T05:13:20Z","timestamp":1757481200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0306453083900458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1983]]}},"alternative-id":["0306453083900458"],"URL":"https:\/\/doi.org\/10.1016\/0306-4530(83)90045-8","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[1983]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Failure of naloxone to reverse apomorphine effects in humans","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/0306-4530(83)90045-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1983 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}